Evidence map›Paper›PMID 28515902›Full record

ArticleAntimicrobial resistance and infection control2017

Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study.

Zeina A Kanafani, Sukayna M Fadlallah, Sarah Assaf, Khalil Anouti, Kohar Annie B Kissoyan, Jad Sfeir, Tamara Nawar, Mohamad Yasmin, Ghassan M Matar

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zeina A KanafaniDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Sukayna M FadlallahDepartment of Experimental Pathology, Immunology and Microbiology, American University of Beirut, Beirut, Lebanon.
Sarah AssafDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Khalil AnoutiDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Kohar Annie B KissoyanDepartment of Experimental Pathology, Immunology and Microbiology, American University of Beirut, Beirut, Lebanon.
Jad SfeirDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Tamara NawarDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Mohamad YasminDepartment of Internal Medicine, American University of Beirut, PO Box 11-0236/11D, Cairo Street, Riad El Solh, Beirut, 1107 2020 Lebanon.
Ghassan M MatarDepartment of Experimental Pathology, Immunology and Microbiology, American University of Beirut, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe objective of this study was to determine whether patients infected with extended-spectrum beta-lactamase (ESBL)-producing organisms are colonized at multiple body sites.

methodsThis was a prospective cohort study at a tertiary care center in Beirut, Lebanon. Hospitalized patients with infections caused by ESBL-producing organisms were included. Cultures were obtained from the primary site of infection as well as from other sites (skin, nasopharynx, urine, rectum). Molecular analysis was performed on isolates to determine clonal relatedness.

resultsOne hundred patients were included in the study. Only 22 patients had positive cultures from sites other than the primary site of infection. The most common ESBL gene was CTX-M-15 followed by TEM-1. In 11 of 22 patients, isolates collected from the same patient were 100% genetically related, while in the remaining patients, genomic relatedness ranged from 42.9% to 97.1%.

conclusionsColonization at sites other than the primary site of infection was not common among our patient population infected with ESBL-producing organisms. The dynamics of transmission of these bacterial strains should be studied in further prospective studies to determine the value of routine active surveillance and the need for expanded precautions in infected and colonized patients.

Indexed as

Antibiotic resistanceColonizationExtended spectrum beta-lactamasesMolecular analysisScreening

Identifiers

PMID28515902
PMCPMC5433240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.